InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,075.02
(
0.45%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

crudeoil24

Send PM Follow Ignore
Followers 800
Posts 50862
Boards Moderated 2
Alias Born 12/12/2004

crudeoil24

Member Level

Re: None

Tuesday, 07/04/2017 12:30:29 PM

Tuesday, July 04, 2017 12:30:29 PM

Post# of 97237
MSDI up 160% > This may be the catalyst that is sending this (LOI) merger, north: MSDI... Larazotide has received FDA Fast Track
prepare for phase 3 clinical trials for larazotide in celiac disease later this year. Larazotide is the only drug which has successfully met its primary endpoint in an efficacy clinical trial for celiac disease.
http://www.innovatebiopharma.com/PressReleases_6June2017.html

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up